Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Toxicokinetics of adefovir dipivoxil and remofovir in 28-day toxicity studies

  • In: SIG Pharmaceutical Biotechnology Posters
  • At: New Orleans (USA) (2004)
  • Type: Poster
  • Poster code: PB-P009
  • By: XU, Christine (Valeant Pharmaceuticals International, Drug Development, Costa Mesa, United States of America)
  • Co-author(s): Vitarella (Valeant Pharmaceuticals International, COSTA MESA, United States of America)
    Lin (Valeant Pharmaceuticals International, COSTA MESA, United States of America)
    Yeh (Valeant Pharmaceuticals International, COSTA MESA, United States of America)
  • Abstract:

    Aim: Adefovir dipivoxil and remofovir are oral prodrugs of the PMEA that indicated for the treatment of chronic hepatitis B. This study was to compare the toxicokinetics of adefovir dipivoxil and remofovir as well as PMEA following repeated doses of adefovir dipivoxil or remofovir for 28 days in rats. Methods: Animals received daily oral..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses